{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:05Z","timestamp":1793442665099,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115456","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:41:00Z","timestamp":1791960060000},"page":"115456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Scalable cultured gut microbiota-derived nanovesicles for oral augmentation of checkpoint blockade therapy"],"prefix":"10.1016","volume":"399","author":[{"given":"Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilupaier","family":"Tayier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangnian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6529","key":"10.1016\/j.jconrel.2026.115456_bb0005","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.jconrel.2026.115456_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"issue":"6667","key":"10.1016\/j.jconrel.2026.115456_bb0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.add7034","article-title":"Probiotic-guided CAR-T cells for solid tumor targeting","volume":"382","author":"Vincent","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115456_bb0020","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jconrel.2020.07.009","article-title":"Bacteria and bacterial derivatives as drug carriers for cancer therapy","volume":"326","author":"Cao","year":"2020","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115456_bb0025","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115456_bb0030","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.21037\/tlcr-2025-973","article-title":"Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study","volume":"14","author":"Du","year":"2025","journal-title":"Transl Lung Cancer Res"},{"issue":"6371","key":"10.1016\/j.jconrel.2026.115456_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.jconrel.2026.115456_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"issue":"7741","key":"10.1016\/j.jconrel.2026.115456_bb0045","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","article-title":"A defined commensal consortium elicits CD8 T cells and anti-cancer immunity","volume":"565","author":"Tanoue","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115456_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal microbiota transplantation: current challenges and future landscapes","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115456_bb0055","first-page":"150","article-title":"Adverse events in fecal microbiota transplantation: a systematic review and meta-analysis","volume":"35","author":"Rapoport","year":"2022","journal-title":"Ann. Gastroenterol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115456_bb0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cgh.2023.09.001","article-title":"Long-term safety outcomes of fecal microbiota transplantation: real-world data over 8 years from the Hong Kong FMT registry","volume":"22","author":"Yau","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115456_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123729","article-title":"Primary and acquired resistance to immunotherapy in lung cancer: unveiling the mechanisms underlying of immune checkpoint blockade therapy","volume":"12","author":"Boyero","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115456_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101993","article-title":"Commensal bacterial hybrid nanovesicles improve immune checkpoint therapy in pancreatic cancer through immune and metabolic reprogramming","volume":"52","author":"Liu","year":"2023","journal-title":"Nano Today"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115456_bb0070","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.ejso.2021.01.002","article-title":"Uptake and survival effects of minimally invasive surgery for lung cancer: a population-based study","volume":"47","author":"Akhtar-Danseh","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115456_bb0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cncr.32468","article-title":"Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)","volume":"126","author":"Bodor","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115456_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"6371","key":"10.1016\/j.jconrel.2026.115456_bb0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115456_bb0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gutjnl-2020-323426","article-title":"Lactobacillus rhamnosus GG induces cGAS\/STING- dependent type I interferon and improves response to immune checkpoint blockade","volume":"71","author":"Si","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115456_bb0100","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1186\/s12967-025-06675-0","article-title":"Parabacteroides johnsonii inhibits the onset and progression of colorectal cancer by modulating the gut microbiota","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"issue":"6264","key":"10.1016\/j.jconrel.2026.115456_bb0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115456_bb0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13073-019-0672-4","article-title":"Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients","volume":"11","author":"Peters","year":"2019","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115456_bb0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF02932091","article-title":"Adaptation of adhesion test using Caco-2 cells for anaerobic bacterium Pseudobutyrivibrio xylanivorans, a probiotic candidate","volume":"52","author":"\u010cepeljnik","year":"2007","journal-title":"Folia Microbiol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115456_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116172","article-title":"A capsular polysaccharide from a healthy human microbiota member activates a Lag-3-NK cell axis to restrain colon cancer and augment immunotherapy","volume":"44","author":"Weis","year":"2025","journal-title":"Cell Rep."},{"issue":"6510","key":"10.1016\/j.jconrel.2026.115456_bb0125","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"issue":"Supplement_1","key":"10.1016\/j.jconrel.2026.115456_bb0130","doi-asserted-by":"crossref","first-page":"120.04","DOI":"10.4049\/jimmunol.208.Supp.120.04","article-title":"Lactobacillus rhamnosus GG re-shapes gut microbiota and triggers STING-type I IFN-dependent antitumor immunity","volume":"208","author":"Wang","year":"2022","journal-title":"J. Immunol."},{"issue":"6446","key":"10.1016\/j.jconrel.2026.115456_bb0135","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1126\/science.aaw7479","article-title":"Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis","volume":"364","author":"Ansaldo","year":"2019","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115456_bb0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6285","key":"10.1016\/j.jconrel.2026.115456_bb0155","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1126\/science.aad8852","article-title":"Durable coexistence of donor and recipient strains after fecal microbiota transplantation","volume":"352","author":"Li","year":"2016","journal-title":"Science"},{"issue":"6\u20137","key":"10.1016\/j.jconrel.2026.115456_bb0160","article-title":"Defined gut microbial communities: promising tools to understand and combat disease","volume":"23","author":"Bayer","year":"2021","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115456_bb0165","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00054-18","article-title":"The use of defined microbial communities to model host-microbe interactions in the human gut","volume":"83","author":"Elzinga","year":"2019","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.jconrel.2026.115456_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1637673","article-title":"Laboratory preparation methods for human-derived fecal microbial suspensions for fecal microbiota transplantation: a review and standardization perspectives","volume":"16","author":"Gong","year":"2025","journal-title":"Front. Microbiol."},{"issue":"19","key":"10.1016\/j.jconrel.2026.115456_bb0175","article-title":"Nanjing consensus on methodology of washed microbiota transplantation","volume":"133","author":"Fecal Microbiota Transplantation-standardization Study, G","year":"2020","journal-title":"Chin. Med. J."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115456_bb0180","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000735","article-title":"Washed microbiota transplantation is associated with improved lipid profiles: long-term efficacy and safety in an observational cohort from South China","volume":"15","author":"Liang","year":"2024","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115456_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170922","article-title":"Profiling living bacteria informs preparation of fecal microbiota transplantations","volume":"12","author":"Chu","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115456_bb0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2021.12.008","article-title":"Establishment and characterization of stable, diverse, fecal-derived in vitro microbial communities that model the intestinal microbiota","volume":"30","author":"Aranda-D\u00edaz","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115456_bb0195","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20178157","article-title":"Deciphering microbial interactions in synthetic human gut microbiome communities","volume":"14","author":"Venturelli","year":"2018","journal-title":"Mol. Syst. Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115456_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.01220-22","article-title":"Drivers of stability and transience in composition-functioning links during serial propagation of litter-decomposing microbial communities","volume":"8","author":"Moore","year":"2023","journal-title":"mSystems"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115456_bb0205","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","article-title":"Exploiting bacteria for cancer immunotherapy","volume":"21","author":"Kwon","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115456_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128156","article-title":"Unraveling the potential of bioengineered microbiome-based strategies to enhance cancer immunotherapy","volume":"296","author":"Hamza","year":"2025","journal-title":"Microbiol. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115456_bb0215","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat. Commun."},{"issue":"6264","key":"10.1016\/j.jconrel.2026.115456_bb0220","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115456_bb0225","article-title":"Microbiome bacterial influencers of host immunity and response to immunotherapy","volume":"5","author":"Yousefi","year":"2024","journal-title":"Cell Rep Med"},{"issue":"13","key":"10.1016\/j.jconrel.2026.115456_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202405159","article-title":"Development of Akkermansia muciniphila membrane-coated mesoporous silica nanoparticles with a cerium oxide core for inflammatory bowel disease treatment","volume":"14","author":"Zhang","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"26","key":"10.1016\/j.jconrel.2026.115456_bb0235","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1016\/j.biomaterials.2012.05.034","article-title":"A membrane vesicle-based dual vaccine against melanoma and Lewis lung carcinoma","volume":"33","author":"Tian","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115456_bb0240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/hv.22130","article-title":"How can nanotechnology help membrane vesicle-based cancer immunotherapy development?","volume":"9","author":"Tian","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115456_bb0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115456_bb0250","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41522-025-00785-9","article-title":"Gut microbiota and SCFAs improve the treatment efficacy of chemotherapy and immunotherapy in NSCLC","volume":"11","author":"Yang","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.jconrel.2026.115456_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2026.103081","article-title":"Pterostilbene-loaded nanoparticles enhance tumor immunotherapy by promoting T cell immunity","volume":"70","author":"Shao","year":"2026","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115456_bb0260","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1172\/JCI87324","article-title":"Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma","volume":"126","author":"Daud","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115456_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102748","article-title":"Tumor cell-derived engineered exosome enhances effective immunotherapy for orthotopic glioblastoma and its recurrences","volume":"63","author":"Li","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115456_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102805","article-title":"Exosomes-incorporated biomaterials boost cancer immunotherapy","volume":"64","author":"Li","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115456_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102650","article-title":"Innovative design of bacterial outer membrane vesicles for vaccine development","volume":"61","author":"Cheng","year":"2025","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115456_bb0280","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41467-021-22308-8","article-title":"Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via plug-and-display technology","volume":"12","author":"Cheng","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115456_bb0285","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.apsb.2025.03.014","article-title":"Targeting copper homeostasis: Akkermansia-derived OMVs co-deliver Atox1 siRNA and elesclomol for cancer therapy","volume":"15","author":"Hamza","year":"2025","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:42:20Z","timestamp":1793439740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":55,"alternative-id":["S0168365926008606"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115456","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scalable cultured gut microbiota-derived nanovesicles for oral augmentation of checkpoint blockade therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115456"}}